Boston Scientific Registry of Deep Brain Stimulation for Treatment of Essential Tremor (ET)

StatusRecruiting
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 9 years 11 months later Dec 2029 → Dec 2039
See other at-risk trials from Boston Scientific Corporation

Record History

The 50 most recent of 69 record versions are accounted for below. See every version on ClinicalTrials.gov ↗

  1. Primary and study completion pushed from Dec 2029 to Dec 2039
    • Eligibility criteria expanded, about 3 words
  2. 7 versions Re-verified since Mar 11, 2026, no change to tracked fieldsv62-v68
  3. Primary and study completion dates: Dec 2028 to Dec 2029v61
  4. 4 versions Re-verified since Sep 11, 2025, no change to tracked fieldsv57-v60
  5. Study sites: 19 to 20v56
Show 36 earlier versionsHide 36 earlier versions
  1. 2 versions Re-verified since Jun 6, 2025, no change to tracked fieldsv54-v55
  2. Study sites revised (19)v53
  3. 5 versions Re-verified since Dec 19, 2024, no change to tracked fieldsv48-v52
  4. Study sites: 18 to 19v47
  5. 4 versions Re-verified since Jul 5, 2024, no change to tracked fieldsv43-v46
  6. Study sites: 17 to 18v42
  7. 2 versions Re-verified since Apr 5, 2024, no change to tracked fieldsv40-v41
  8. Study sites: 16 to 17v39
  9. Study sites: 15 to 16v38
  10. Re-verified, no change to tracked fieldsv37
  11. Study sites: 14 to 15v36
  12. Re-verified, no change to tracked fieldsv35
  13. Study sites: 13 to 14v34
  14. 6 versions Re-verified since May 8, 2023, no change to tracked fieldsv28-v33
  15. Site details revised at 1 of 13 sitesv27
  16. Re-verified, no change to tracked fieldsv26
  17. Primary and study completion dates: Dec 31, 2028 to Dec 2028v25
  18. Re-verified, no change to tracked fieldsv24
  19. Study sites: 12 to 13v23
  20. Site details revised at 1 of 12 sitesv22
  21. 2 versions Re-verified since Sep 12, 2022, no change to tracked fieldsv20-v21
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To compile characteristics of real-world outcomes for Boston Scientific Corporation's commercially approved Deep Brain Stimulation (DBS) Systems, when used according to the applicable Directions for Use, for the treatment of Essential Tremor.
Trial Details
NCT Number NCT04032470
Lead Sponsor Boston Scientific Corporation
Conditions
(from sponsor)		 Essential Tremor
Related terms Essential Tremor
Enrollment 500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov